 Further demonstrating its commitment to expand and protect its Intellectual Property IP portfolio, Microbot Medical Inc. MBOT was issued a Notice of Allowance for patent application No. 15936,878 by the U.S. Patent and Trademark Office USPTO. The allowed patent application covers the Companys TipCATTM technology platform. As we near the expected FDA pre-submission for our first product, the Self Cleaning Shunt SCSTM, we have also experienced an acceleration in the expansion of our patent estate with this latest allowance being the 5th to date in 2019 and across several global jurisdictions, including North America and Europe, said Harel Gadot, Chief Executive Officer, President, and Chairman. 